The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10588967 B1

PDF
Full Text
Expired
Date of Patent:
Mar. 17, 2020

Filed:

Mar. 31, 2015
Applicant:

Ucl Business Plc, London, GB;

Inventors:

Martin Pulé, London, GB;

Shaun Cordoba, London, GB;

Khai Kong, London, GB;

Assignee:

UCL BUSINESS LTD, London, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 38/17 (2006.01); C07K 14/725 (2006.01); C12N 5/0783 (2010.01); A61K 31/166 (2006.01); A61K 31/436 (2006.01); A61K 31/4545 (2006.01); A61K 38/45 (2006.01); A61K 38/52 (2006.01); C07K 14/705 (2006.01); C12N 9/12 (2006.01); C12N 9/90 (2006.01); C12N 5/10 (2006.01); A61K 48/00 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61K 31/166 (2013.01); A61K 31/436 (2013.01); A61K 31/4545 (2013.01); A61K 38/177 (2013.01); A61K 38/1774 (2013.01); A61K 38/45 (2013.01); A61K 38/52 (2013.01); A61K 48/00 (2013.01); C07K 14/4702 (2013.01); C07K 14/705 (2013.01); C07K 14/7051 (2013.01); C07K 14/70517 (2013.01); C07K 14/70521 (2013.01); C07K 14/70578 (2013.01); C07K 16/28 (2013.01); C07K 16/2803 (2013.01); C12N 5/0636 (2013.01); C12N 5/0646 (2013.01); C12N 5/10 (2013.01); C12N 9/12 (2013.01); C12N 9/90 (2013.01); C12Y 207/11001 (2013.01); C12Y 502/01008 (2013.01); C07K 2317/622 (2013.01); C07K 2319/00 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/70 (2013.01); C07K 2319/74 (2013.01);
Abstract

The present invention relates to a chimeric antigen receptor (CAR) signalling system comprising; (i) a receptor component comprising an extracellular antigen-binding domain, a transmembrane domain and a intracellular first chemical inducer of dimerization binding domain 1 (CBD1); and (ii) an intracellular signalling component comprising a signalling domain and a second chemical inducer of dimerization binding domain 2 (CBD2); wherein CBD1 and CBD2 are capable of simultaneously binding to a chemical inducer of dimerization (CID); wherein, in the absence of the CID, binding of the antigen-binding component to antigen does not result in signalling through the signalling component; whilst, in the presence of the CID, the receptor component and the signalling component heterodimerize and binding of the antigen-binding domain to antigen results in signalling through the signalling domain.


Find Patent Forward Citations

Quick Actions:

Pulé, Martin. (2020). Chimeric antigen receptor (car) signalling system (U.S. Patent No. 10588967). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10588967

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…